These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30691320)

  • 1. Myricetin nanoliposomes induced SIRT3-mediated glycolytic metabolism leading to glioblastoma cell death.
    Wang G; Wang JJ; Wang YZ; Feng S; Jing G; Fu XL
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S180-S191. PubMed ID: 30691320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
    Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
    J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of SIRT1-mediated mitochondrial and Akt pathways in glioblastoma cell death induced by Cotinus coggygria flavonoid nanoliposomes.
    Wang G; Wang JJ; To TS; Zhao HF; Wang J
    Int J Nanomedicine; 2015; 10():5005-23. PubMed ID: 26345416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells.
    Tang XJ; Huang KM; Gui H; Wang JJ; Lu JT; Dai LJ; Zhang L; Wang G
    Int J Nanomedicine; 2016; 11():4991-5002. PubMed ID: 27757032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility.
    Zhao HF; Wang G; Wu CP; Zhou XM; Wang J; Chen ZP; To ST; Li WP
    CNS Neurol Disord Drug Targets; 2018; 17(7):557-567. PubMed ID: 29886836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.
    Vallejo FA; Shah SS; de Cordoba N; Walters WM; Prince J; Khatib Z; Komotar RJ; Vanni S; Graham RM
    J Neurooncol; 2020 Apr; 147(2):317-326. PubMed ID: 32096068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.
    Polson ES; Kuchler VB; Abbosh C; Ross EM; Mathew RK; Beard HA; da Silva B; Holding AN; Ballereau S; Chuntharpursat-Bon E; Williams J; Griffiths HBS; Shao H; Patel A; Davies AJ; Droop A; Chumas P; Short SC; Lorger M; Gestwicki JE; Roberts LD; Bon RS; Allison SJ; Zhu S; Markowetz F; Wurdak H
    Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
    Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
    Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Kinetics and Mechanism of Flavonoids Extracted from Cotinus coggygria Scop. Against Glioblastoma Cancer.
    Wang G; Wang JJ; Du L; Fei L; To ST
    Nutr Cancer; 2016; 68(8):1357-1368. PubMed ID: 27673410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma.
    Kim J; Han J; Jang Y; Kim SJ; Lee MJ; Ryu MJ; Kweon GR; Heo JY
    Int J Oncol; 2015 Sep; 47(3):1009-16. PubMed ID: 26202438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.
    Chiasserini D; Davidescu M; Orvietani PL; Susta F; Macchioni L; Petricciuolo M; Castigli E; Roberti R; Binaglia L; Corazzi L
    J Proteomics; 2017 Jan; 152():329-338. PubMed ID: 27890797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
    Tanaka K; Sasayama T; Irino Y; Takata K; Nagashima H; Satoh N; Kyotani K; Mizowaki T; Imahori T; Ejima Y; Masui K; Gini B; Yang H; Hosoda K; Sasaki R; Mischel PS; Kohmura E
    J Clin Invest; 2015 Apr; 125(4):1591-602. PubMed ID: 25798620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
    Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
    Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
    Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
    Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
    Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
    Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fraxinellone inhibits progression of glioblastoma via regulating the SIRT3 signaling pathway.
    Shi J; Sun S; Xing S; Huang C; Huang Y; Wang Q; Xue X; Chen Z; Wang Y; Huang Z
    Biomed Pharmacother; 2022 Sep; 153():113416. PubMed ID: 36076484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of gallic acid on cytotoxicity, Ca(2+) homeostasis and ROS production in DBTRG-05MG human glioblastoma cells and CTX TNA2 rat astrocytes.
    Hsu SS; Chou CT; Liao WC; Shieh P; Kuo DH; Kuo CC; Jan CR; Liang WZ
    Chem Biol Interact; 2016 May; 252():61-73. PubMed ID: 27060209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ
    Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.
    Zhao HF; Wang J; Jiang HR; Chen ZP; To SS
    J Exp Clin Cancer Res; 2016 May; 35():78. PubMed ID: 27176481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
    Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
    PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.